MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 1
Terminated
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2009-12-04
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 27
- Registration Number
- NCT01026844
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
Not Applicable
Withdrawn
- Conditions
- Chronic Kidney DiseaseVitamin D Deficiency
- Interventions
- First Posted Date
- 2009-12-04
- Last Posted Date
- 2015-09-23
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT01026363
- Locations
- 🇺🇸
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
Comparison of Bovine Carotid Artery and Expanded Polytetrafluoroethylene (ePTFE) for Permanent Hemodialysis Access
Not Applicable
Completed
- Conditions
- Kidney FailureRenal Dialysis
- Interventions
- Procedure: Grafts placement
- First Posted Date
- 2009-11-30
- Last Posted Date
- 2009-11-30
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 57
- Registration Number
- NCT01021839
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)
Phase 1
Completed
- Conditions
- Recurrent Respiratory Papillomatosis
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT01020747
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Skills Training for Adolescents With ADHD
Not Applicable
Completed
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Behavioral: Cognitive Behavioral Therapy (CBT)
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT01019252
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder
Not Applicable
Completed
- Conditions
- Body Dysmorphic Disorder
- Interventions
- Behavioral: Cognitive-Behavioral Therapy
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 13
- Registration Number
- NCT01002326
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Does Mindfulness Training Change the Processing of Social Threat?
Not Applicable
Completed
- Conditions
- HealthyStress
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT00992875
- Locations
- 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States
Rule Out Myocardial Infarction by Computer Assisted Tomography
Completed
- Conditions
- Acute Coronary SyndromeMyocardial InfarctionUnstable Angina Pectoris
- Interventions
- Radiation: Cardiac Computed Tomography
- First Posted Date
- 2009-10-06
- Last Posted Date
- 2009-10-06
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 368
- Registration Number
- NCT00990262
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
The Impact of GlowCaps Connect™ and Its Services on Hypertension Medication Adherence
Not Applicable
Completed
- Conditions
- Medication Adherence
- Interventions
- Other: GlowCaps Connect systemOther: Glow cap system - deactivated
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 139
- Registration Number
- NCT00985452
High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
Phase 2
Completed
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Dietary Supplement: OxepaDietary Supplement: Jevity 1.0Dietary Supplement: Jevity 1.5
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2015-02-27
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT00983983
- Locations
- 🇺🇸
University of California at Irvine, Irvine, California, United States
🇺🇸Sarasota Memorial Hospital, Sarasota, Florida, United States
🇺🇸Emory University School of Medicine, Atlanta, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath